T

Tongling Jieya Biologic Technology Co Ltd
SZSE:301108

Watchlist Manager
Tongling Jieya Biologic Technology Co Ltd
SZSE:301108
Watchlist
Price: 28.1 CNY -0.64% Market Closed
Market Cap: 2.3B CNY
Have any thoughts about
Tongling Jieya Biologic Technology Co Ltd?
Write Note

Tongling Jieya Biologic Technology Co Ltd
Other Long-Term Assets

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Tongling Jieya Biologic Technology Co Ltd
Other Long-Term Assets Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Other Long-Term Assets CAGR 3Y CAGR 5Y CAGR 10Y
T
Tongling Jieya Biologic Technology Co Ltd
SZSE:301108
Other Long-Term Assets
ÂĄ14.5m
CAGR 3-Years
10%
CAGR 5-Years
20%
CAGR 10-Years
N/A
Hengan International Group Company Ltd
HKEX:1044
Other Long-Term Assets
ÂĄ751m
CAGR 3-Years
-2%
CAGR 5-Years
14%
CAGR 10-Years
-6%
Proya Cosmetics Co Ltd
SSE:603605
Other Long-Term Assets
ÂĄ193.2m
CAGR 3-Years
36%
CAGR 5-Years
23%
CAGR 10-Years
N/A
Yunnan Botanee Bio-Technology Group Co Ltd
SZSE:300957
Other Long-Term Assets
ÂĄ233.4m
CAGR 3-Years
82%
CAGR 5-Years
54%
CAGR 10-Years
N/A
By-health Co Ltd
SZSE:300146
Other Long-Term Assets
ÂĄ286.7m
CAGR 3-Years
-3%
CAGR 5-Years
18%
CAGR 10-Years
N/A
G
Giant Biogene Holding Co Ltd
HKEX:2367
Other Long-Term Assets
ÂĄ119m
CAGR 3-Years
32%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

Tongling Jieya Biologic Technology Co Ltd
Glance View

Market Cap
2.3B CNY
Industry
Consumer products

Tongling Jieya Biologic Technology Co., Ltd. engages in the research and development, production, and sale of wet wipes. The company is headquartered in Tongling, Anhui and currently employs 798 full-time employees. The company went IPO on 2021-12-03. The firm's main businesses are the research and development, production and sales of sanitary products. The firm's wet wipes products include baby series, adult functional series, antibacterial disinfection series, household cleaning series, medical care series and pet cleaning series. The firm is also engaged in the production of facial masks.

Intrinsic Value
22.97 CNY
Overvaluation 18%
Intrinsic Value
Price
T

See Also

What is Tongling Jieya Biologic Technology Co Ltd's Other Long-Term Assets?
Other Long-Term Assets
14.5m CNY

Based on the financial report for Dec 31, 2023, Tongling Jieya Biologic Technology Co Ltd's Other Long-Term Assets amounts to 14.5m CNY.

What is Tongling Jieya Biologic Technology Co Ltd's Other Long-Term Assets growth rate?
Other Long-Term Assets CAGR 5Y
20%

Over the last year, the Other Long-Term Assets growth was 130%. The average annual Other Long-Term Assets growth rates for Tongling Jieya Biologic Technology Co Ltd have been 10% over the past three years , 20% over the past five years .

Back to Top